TOKYO -- Japan's SoftBank Group will invest $900 million in a U.S. developer of equipment for genetic analysis, building on its earlier investment in the company.
Technology
SoftBank invests $900m more in Nasdaq-listed US gene tech maker
Pacific Biosciences shares soar following latest fundraising from Japanese group
SoftBank Group has focused more on public companies recently, looking to diversify its investments. (Photo by Yoichi Iwata)
Read Next
Latest on Technology
